Topic: Drug reform

Draft PMPRB guidelines include changes to reference countries, drug price factors

Staff | November 25, 2019 / News

Proposed changes to Ontario drug rules target generics pricing, biosimilar listing process

Staff | November 14, 2019 / News

Alberta budget includes changes to public pensions, expanded biosimilars initiative

Kelsey Rolfe | October 28, 2019 / News

Editorial: Federal election promises must focus on Canada’s evolving workforce

Jennifer Paterson | October 18, 2019 / News

Liberals pledging to boost investments in mental health, pharmacare

Staff | September 24, 2019 / News

Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices

Kelsey Rolfe | September 23, 2019 / News

Federal election platforms include health-care, pension policy proposals

Staff | September 17, 2019 / News

Canadian health benefits costs expected to grow 6% in 2020: report

Staff | September 16, 2019 / News

Pharma companies launching challenge to PMPRB changes

Kelsey Rolfe | August 27, 2019 / News

What will PMPRB drug pricing changes mean for plan sponsors?

Kelsey Rolfe | August 15, 2019 / News